Literature DB >> 17257740

Should we abandon the FISH test?

Alan M Nieder, Mark S Soloway, Harry W Herr.   

Abstract

Mesh：

Year:  2007        PMID： 17257740     DOI： 10.1016/j.eururo.2007.01.044

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  7 in total

Review 1.  [Upper tract urothelial carcinoma. An update on clinical and pathological prognostic factors].

Authors:  M Rink; M Adam; J Hansen; F K Chun; S A Ahyai; M Remzi; T Schlomm; O Engel; R Heuer; C Eichelberg; M Fisch; R Dahlem; S F Shariat
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

2.  Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years?

Authors:  Mesut Remzi; Shahrokh Shariat; Wilhelm Huebner; Harun Fajkovic; Christian Seitz
Journal:  Ther Adv Urol       Date:  2011-04

3.  A Festschrift in Honor of Edward M. Messing, MD, FACS.

Authors:  Jean V Joseph; Ralph Brasacchio; Chunkit Fung; Jay Reeder; Kevin Bylund; Deepak Sahasrabudhe; Shu Yuan Yeh; Ahmed Ghazi; Patrick Fultz; Deborah Rubens; Guan Wu; Eric Singer; Edward Schwarz; Supriya Mohile; James Mohler; Dan Theodorescu; Yi Fen Lee; Paul Okunieff; David McConkey; Hani Rashid; Chawnshang Chang; Yves Fradet; Khurshid Guru; Janet Kukreja; Gerald Sufrin; Yair Lotan; Howard Bailey; Katia Noyes; Seymour Schwartz; Kathy Rideout; Gennady Bratslavsky; Steven C Campbell; Ithaar Derweesh; Per-Anders Abrahamsson; Mark Soloway; Leonard Gomella; Dragan Golijanin; Robert Svatek; Thomas Frye; Seth Lerner; Ganesh Palapattu; George Wilding; Michael Droller; Donald Trump
Journal:  Bladder Cancer       Date:  2018-10-03

Review 4.  Prognostic factors for upper urinary tract urothelial carcinoma.

Authors:  Thomas F Chromecki; Karim Bensalah; Mesut Remzi; Grégory Verhoest; Eugene K Cha; Douglas S Scherr; Giacomo Novara; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2011-07-05       Impact factor: 14.432

Review 5.  What are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future?

Authors:  Mohamed Ismat Abdulmajed; Eyüp Burak Sancak; Berkan Reşorlu; Gydhia Zuhair Al-Chalaby
Journal:  Turk J Urol       Date:  2014-10-15

Review 6.  UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives.

Authors:  Takashi Nagai; Taku Naiki; Toshiki Etani; Keitaro Iida; Yusuke Noda; Nobuhiko Shimizu; Teruki Isobe; Satoshi Nozaki; Takehiko Okamura; Ryosuke Ando; Noriyasu Kawai; Takahiro Yasui
Journal:  Transl Androl Urol       Date:  2021-04

7.  [Fluorescence in situ hybridization. A new diagnostic dimension in cytology].

Authors:  S Savic; L Bubendorf
Journal:  Pathologe       Date:  2007-09       Impact factor: 0.973
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.